Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2027 346

  1. Primary completion Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05465031

  2. Study completion Safest Choice of Antihypertensive Regimen for Postpartum Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05551104

  3. Primary completion Safest Choice of Antihypertensive Regimen for Postpartum Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05551104

  4. Study completion Improving CRT Outcome With Non-Invasive Cardiac Mapping Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05564793

  5. Primary completion Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05627375

  6. Study completion Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05630586

  7. Study completion COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05633810

  8. Primary completion COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05633810

  9. Study completion Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05691244

  10. Study completion Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05844462

  11. Study completion The Danish Out-of-Hospital Cardiac Arrest Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05895838

  12. Study completion The THOR IDE Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05916950

  13. Primary completion First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05939076

  14. Study completion ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05988411

  15. Primary completion ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05988411

  16. Study completion Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05988450

  17. Study completion A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06008197

  18. Study completion Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06093932

  19. Primary completion MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06128629

  20. Primary completion Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06138821

  21. Study completion Dapagliflozin in STEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06174753

  22. Primary completion The STOP-MED CTRCD Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06183437

  23. Study completion REstoration of VItamin D in Pulmonary Arterial Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06258850

  24. Primary completion Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06259019

  25. Primary completion Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06365502

  26. Study completion Henagliflozin's Impact on Prediabetes Remission Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06448130

  27. Primary completion Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06486012

  28. Primary completion Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06499857

  29. Study completion Transcutaneous Electrical Acupoint Stimulation on Blood Pressure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06537167

  30. Primary completion Transcutaneous Electrical Acupoint Stimulation on Blood Pressure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06537167

  31. Study completion Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06548971

  32. Primary completion Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06548971

  33. Study completion Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06682351

  34. Primary completion Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06682351

  35. Study completion Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06736574

  36. Study completion Effect of Specific Mode Electroacupuncture Stimulation Combined with NGF on Dysphagia After Ischaemic Stroke: a Pilot Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06737549

  37. Primary completion Effect of Specific Mode Electroacupuncture Stimulation Combined with NGF on Dysphagia After Ischaemic Stroke: a Pilot Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06737549

  38. Study completion Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06756945

  39. Study completion Landiolol in Mitral Valve Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06793670

  40. Study completion A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06863987

  41. Primary completion A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06863987

  42. Study completion Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06935591

  43. Primary completion SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06955260

  44. Study completion A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07021963

  45. Primary completion A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07021963

  46. Study completion Boston Medical Center Ultrasound Decongestion Study in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07096726

  47. Primary completion Boston Medical Center Ultrasound Decongestion Study in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07096726

  48. Study completion RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07187570

  49. Primary completion RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07187570

  50. Primary completion A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07194265

  51. Study completion REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07216170

  52. Primary completion REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07216170

  53. Primary completion A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07318155

  54. Primary completion A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07359807

  55. Study completion Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07376447

  56. Primary completion Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07412626

  57. Primary completion T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07422831

  58. Primary completion QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07441317

  59. Study completion TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07460960

  60. Primary completion TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07460960

  61. Study completion WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07523269

  62. Study completion Butylphthalide for Brain Edema After Endovascular Treatment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07528456

  63. Primary completion Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07529028

  64. Study completion Portable MRI for Pediatric Hypoxic Ischemic Brain Injury Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07577336

  65. Primary completion Portable MRI for Pediatric Hypoxic Ischemic Brain Injury Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07577336

  66. Study completion SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07631780

  67. Primary completion SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07631780

  68. Study completion Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687706

  69. Study completion PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07741253

  70. Primary completion PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07741253

  71. Primary completion Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07828730

  72. Primary completion A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07833098

  73. Primary completion OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07855614

  74. Study completion Upper Extremity Orthoses Combined With Occupational Therapy in Subacute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07864090

  75. Primary completion Upper Extremity Orthoses Combined With Occupational Therapy in Subacute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07864090

  76. Study completion Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07864168

  77. Primary completion Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07864168

  78. Study completion Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Related to Cerebral Small Vessel Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07891650

  79. Primary completion Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07041281

  80. Study completion Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05591040

  81. Primary completion Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05591040

  82. Primary completion SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05852704

  83. Study completion Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06096246

  84. Primary completion Study of ALXN2220 Versus Placebo in Adults With ATTR-CM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06183931

  85. Study completion A Study of TAK-755 in Adults With Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07392450

  86. Primary completion A Study of TAK-755 in Adults With Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07392450

  87. Primary completion Venous Ethanol for Ventricular Tachycardia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05511246

  88. Primary completion Edge-to-edge Mitral Valve Repair in ATTR-CM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06075823

  89. Study completion ULTRA-EVOLUT RCT: A Comparison of Latest-Generation TAVR Valves Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07545369

  90. Study completion Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05047198

  91. Study completion Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06657209

  92. Primary completion Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06657209

  93. Study completion BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06722196

  94. Study completion PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07174375

  95. Primary completion PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07174375

  96. Primary completion Digoxin After Acute Heart Failure (DIG-DICA) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07321509

  97. Primary completion DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07229248

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter Registry record

    Expected 2021-12-01; that period ended on 2021-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04141553

  2. Primary completion Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter Registry record

    Expected 2021-12-01; that period ended on 2021-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04141553

  3. Study completion Coronavirus (COVID-19) ACEi/ARB Investigation Registry record

    Expected 2021-12-01; that period ended on 2021-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04330300

  4. Primary completion Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes Registry record

    Expected 2021-12-01; that period ended on 2021-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04373967

  5. Primary completion Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS® Registry record

    Expected 2021-12-01; that period ended on 2021-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04570865

  6. Study completion Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke Registry record

    Expected 2021-12-01; that period ended on 2021-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04950790

  7. Primary completion Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke Registry record

    Expected 2021-12-01; that period ended on 2021-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04950790

  8. Study completion Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes Registry record

    Expected 2021-12-02; that period ended on 2021-12-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04373967

  9. Primary completion Remote Monitoring System for Patients, Who Had Myocardial Infarction Registry record

    Expected 2021-12-03; that period ended on 2021-12-03.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04424368

  10. Primary completion Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia Registry record

    Expected 2021-12-15; that period ended on 2021-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04438096

  11. Study completion Comparative Evaluation of the McGrath Videolaryngoscope and the Direct Laryngoscopy for Tracheal Intubation in the Prehospital Setting Registry record

    Expected 2021-12-15; that period ended on 2021-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04930419

  12. Primary completion Comparative Evaluation of the McGrath Videolaryngoscope and the Direct Laryngoscopy for Tracheal Intubation in the Prehospital Setting Registry record

    Expected 2021-12-15; that period ended on 2021-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04930419

  13. Primary completion A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT Registry record

    Expected 2021-12-20; that period ended on 2021-12-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03716011

  14. Study completion rTMS in Aphasic Patients With Neuroimage Assessments Registry record

    Expected 2021-12-23; that period ended on 2021-12-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03059225

  15. Primary completion rTMS in Aphasic Patients With Neuroimage Assessments Registry record

    Expected 2021-12-23; that period ended on 2021-12-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03059225

  16. Study start The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients Registry record

    Expected 2021-12-29; that period ended on 2021-12-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04365517

  17. Study completion Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan Registry record

    Expected 2021-12-30; that period ended on 2021-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03699215

  18. Study completion Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System Registry record

    Expected 2021-12-30; that period ended on 2021-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03788590

  19. Study completion LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention Registry record

    Expected 2021-12-30; that period ended on 2021-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04060914

  20. Study completion Chinese Medicine Treat for Hypertensive Renal Injury Registry record

    Expected 2021-12-30; that period ended on 2021-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04078711

  21. Study completion Early Treatment of ARNI on Myocardial Remodeling and Progress Registry record

    Expected 2021-12-30; that period ended on 2021-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04342351

  22. Primary completion WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease Registry record

    Expected 2021-12-30; that period ended on 2021-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04551456

  23. Study completion The Evaluation of Consistency by Finger Stick Blood Glucose or Venous Blood Glucose of Flash Glucose Monitoring in Different Infiltration Time Registry record

    Expected 2021-12-30; that period ended on 2021-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04797416

  24. Primary completion The Evaluation of Consistency by Finger Stick Blood Glucose or Venous Blood Glucose of Flash Glucose Monitoring in Different Infiltration Time Registry record

    Expected 2021-12-30; that period ended on 2021-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04797416

  25. Study completion The Hemodynamic Response to Prolonged Dobutamine Infusion Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01042873

  26. Study start The Application of a Wireless Sensor Technology for Vital Statistics in CHILDREN AND ADULTS Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01845506

  27. Study completion Transcatheter Aortic Valve Replacement System Pivotal Trial Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02163850

  28. Study completion Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02315287

  29. Primary completion Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02315287

  30. Primary completion European Sleep Apnea and Sudden CArdiac Death ProjEct Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02506166

  31. Study completion Percutaneous Intervention Versus Surgery in the Treatment of Common Femoral Artery Lesions Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02517827

  32. Study completion Sleep Study-Guided Multidisciplinary Therapy for Patients Presenting With Acute Coronary Syndrome Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02599298

  33. Study completion Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02601781

  34. Study completion Effect of Melatonin on Cardiometabolic Risk- FULL Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02681887

  35. Study completion Cilostazol Following Peripheral Endovascular Procedures Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02770274

  36. Primary completion Cilostazol Following Peripheral Endovascular Procedures Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02770274

  37. Primary completion PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02895737

  38. Primary completion Pupillometry in Horner's Syndrome Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02978079

  39. Primary completion A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03018665

  40. Study completion Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03062397

  41. Primary completion Tenecteplase in Wake-up Ischaemic Stroke Trial Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03181360

  42. Study completion Early Management Strategies of Acute Heart Failure for Patients With NSTEMI Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03189901

  43. Primary completion Early Management Strategies of Acute Heart Failure for Patients With NSTEMI Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03189901

  44. Study completion Trial of EXenatide in Acute Ischaemic Stroke Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03287076

  45. Study completion High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03403556

  46. Study completion Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03418974

  47. Primary completion Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03418974

  48. Study start Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03423511

  49. Primary completion Multifactorial Intervention on Diabetes (MIDiab Study) Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03430284

  50. Study completion Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03519737

  51. Study completion HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03550859

  52. Primary completion HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03550859

  53. Study completion Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY) Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03664414

  54. Primary completion MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03705312

  55. Study completion Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03764722

  56. Primary completion Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03764722

  57. Study completion Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03775746

  58. Primary completion Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03775746

  59. Study completion Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients. Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03797729

  60. Study completion CUHK Jockey Club HOPE 4 Care Programme - Ankle Robot Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03808428

  61. Primary completion CUHK Jockey Club HOPE 4 Care Programme - Ankle Robot Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03808428

  62. Primary completion Clinical Investigation of ENO/TEO/OTO Pacing System Under MRI Environment Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03811691

  63. Primary completion rTMS and Robotic Gait Training in Patients With Stroke Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03817385

  64. Study completion CUHK Jockey Club HOPE 4 Care Programme - FES Bike Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03848624

  65. Primary completion CUHK Jockey Club HOPE 4 Care Programme - FES Bike Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03848624

  66. Study completion Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03851432

  67. Study completion Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE) Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03891277

  68. Primary completion Atrial Sensing Capability for Better Detection of Atrial Fibrillation Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03932604

  69. Study completion A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03950843

  70. Study completion Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT) Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04041167

  71. Study completion Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04146155

  72. Primary completion Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04146155

  73. Study completion Xingnaojing for Mild-to-severe Acute Ischemic Stroke Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04150835

  74. Primary completion Xingnaojing for Mild-to-severe Acute Ischemic Stroke Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04150835

  75. Primary completion New Designed ePTFE Valved Conduits for Surgical Reconstruction of Right-ventricular Outflow Tract Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04152967

  76. Study completion Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04161170

  77. Study completion Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04169269

  78. Study completion Influence of the PEPA Membrane on the Undernutrition Syndrome Inflammation in Chronic Hemodialysis Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04185571

  79. Study completion Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04275219

  80. Primary completion Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04275219

  81. Primary completion Wearable Devices for Secondary Prevention of Ischemic Stroke Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04282993

  82. Study completion Safety and Efficacy of Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04285060

  83. Study completion Use of ReDS Technology in Patients With Acute Heart Failure Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04305717

  84. Primary completion Use of ReDS Technology in Patients With Acute Heart Failure Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04305717

  85. Study completion Robot-assisted Therapy Combined With Mirror Priming in Upper Limb Training in Stroke Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04326140

  86. Primary completion Robot-assisted Therapy Combined With Mirror Priming in Upper Limb Training in Stroke Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04326140

  87. Primary completion Implementing Standards of Care for Heart Failure Patients in General Practice - A Regional Disease Management Program Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04334447

  88. Study completion Remote Monitoring System for Patients, Who Had Myocardial Infarction Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04424368

  89. Primary completion Comparative Analysis in Detection of Atrial Arrhythmia and ECG Quality in Three Different Insertable Cardiac Monitors Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04471584

  90. Study completion VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04655742

  91. Study completion Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04670809

  92. Primary completion Natural History of COVID-19-Related Atrial Fibrillation Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04830774

  93. Study start Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP) Registry record

    Expected 2021-12; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05105321

  94. Study start Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD Registry record

    Expected 2021-12-31; that period ended on 2021-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05169021

  95. Study start IABP In AMI Patients With SCAI-B Study Registry record

    Expected 2022-01-01; that period ended on 2022-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04989777

  96. Study start The Protective Effect of Prostaglandin on Coronary Microcirculation and Ventricular Remodeling After Reperfusion Therapy in Acute ST-segment Elevation Myocardial Infarction Registry record

    Expected 2022-01-01; that period ended on 2022-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05043558

  97. Study start The Effects of TMZ on Diabetic Nephropathy Registry record

    Expected 2022-01-01; that period ended on 2022-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05147194

  98. Study completion COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes Registry record

    Expected 2022-01-05; that period ended on 2022-01-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04723550

  99. Primary completion The Protective Effect of Prostaglandin on Coronary Microcirculation and Ventricular Remodeling After Reperfusion Therapy in Acute ST-segment Elevation Myocardial Infarction Registry record

    Expected 2022-01-10; that period ended on 2022-01-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05043558

  100. Study completion The Protective Effect of Prostaglandin on Coronary Microcirculation and Ventricular Remodeling After Reperfusion Therapy in Acute ST-segment Elevation Myocardial Infarction Registry record

    Expected 2022-01-12; that period ended on 2022-01-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05043558